1,200
Participants
Start Date
June 12, 2023
Primary Completion Date
May 28, 2025
Study Completion Date
July 31, 2025
Ask-Advise-Refer
All patients will be asked if they smoke, advised to quit, and referred to the state quitline
Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release
14 mg transdermal nicotine patch
Nicotine lozenge
4mg nicotine lozenge
Hennepin Healthcare Research Institute, Minneapolis
Lead Sponsor
Medical University of South Carolina
OTHER
Massachusetts General Hospital
OTHER
Northwestern University
OTHER
HealthPartners Institute
OTHER
University of Alabama at Birmingham
OTHER
Kaiser Permanente
OTHER
University of Rochester
OTHER
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
Hennepin Healthcare Research Institute
OTHER